JOINN Laboratories (China) Co., Ltd.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: CNE100004BP3

HKD

19.86

5.06 (34.19%)

May 22

HKG

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Viva Biotech Holdings

Alphamab Oncology

Frontage Holdings Corp.

JOINN Laboratories (China) Co., Ltd.

Jacobio Pharmaceuticals Group Co., Ltd.

Sirnaomics Ltd.

CanSino Biologics, Inc.

Beijing Lüzhu Biotechnology Co., Ltd.

Laekna, Inc.

Ascentage Pharma Group International Co., Ltd.

Ascletis Pharma, Inc.

Why is JOINN Laboratories (China) Co., Ltd. ?

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

The company is Net-Debt Free

Flat results in Dec 24

RAW MATERIAL COST(Y) Grown by 47.66% (YoY)

With ROE of 0.35%, it has a Very Expensive valuation with a 3.02 Price to Book Value

The stock is trading at a discount compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 87.01%, its profits have fallen by -89.6%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is JOINN Laboratories (China) Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

JOINN Laboratories (China) Co., Ltd.

-100.0%

1.83

76.62%

Hang Seng Hong Kong

8.76%

0.45

19.63%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

11.98%

EBIT Growth (5y)

-184.80%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.26

Sales to Capital Employed (avg)

0.27

Tax Ratio

14.46%

Dividend Payout Ratio

31.89%

Pledged Shares

Institutional Holding

0.78%

ROCE (avg)

8.78%

ROE (avg)

6.56%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

872

Industry P/E

Price to Book Value

3.02

EV to EBIT

-236.86

EV to EBITDA

1055.73

EV to Capital Employed

3.89

EV to Sales

13.40

PEG Ratio

Dividend Yield

0.01%

ROCE (Latest)

-1.64%

ROE (Latest)

0.35%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is not working for JOINN Laboratories (China) Co., Ltd.

Raw Material Cost

Grown by 47.66% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales